- Home
- CPA vs GH Comparison
CPA vs GH Comparison
Compare CPA & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPA | GH |
|---|---|---|
| Founded | 1947 | 2011 |
| Country | Panama | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 17.3B |
| IPO Year | 2005 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CPA | GH |
|---|---|---|
| Price | $150.59 | $131.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 19 |
| Target Price | ★ $159.40 | $119.79 |
| AVG Volume (30 Days) | 315.6K | ★ 2.3M |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.09% | N/A |
| EPS Growth | N/A | ★ 6.74 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $982,021,000.00 |
| Revenue This Year | $15.51 | $33.30 |
| Revenue Next Year | $7.25 | $28.27 |
| P/E Ratio | $9.05 | ★ N/A |
| Revenue Growth | N/A | ★ 32.88 |
| 52 Week Low | $99.32 | $40.36 |
| 52 Week High | $156.41 | $135.00 |
Technical Indicators
Market Signals| Indicator | CPA | GH |
|---|---|---|
| Relative Strength Index (RSI) | 66.99 | 65.32 |
| Support Level | $111.25 | $122.76 |
| Resistance Level | $156.41 | $134.28 |
| Average True Range (ATR) | 5.22 | 6.05 |
| MACD | 0.72 | -1.09 |
| Stochastic Oscillator | 92.13 | 73.70 |
Price Performance
Historical ComparisonAbout CPA Copa Holdings S.A.
Copa Holdings SA is a provider of airline passenger and cargo services through its subsidiaries. The company operates through the air transportation segment. It offers international air transportation for passengers, cargo, and mail, operating from its Panama City hub in the Republic of Panama, and domestic and international air transportation for passengers, cargo, and mail with a point-to-point route network through Copa Colombia, a Colombian air carrier. The company's geographical segments are North America, South America, Central America, and the Caribbean. It derives the maximum revenue from North America.
About GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.